News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Phase Bioscience, Inc. Announces Licensing Agreement With Duke University



11/8/2006 11:07:41 AM

DURHAM, N.C.--(BUSINESS WIRE)--Phase Bioscience, Inc. (PhaseBio) announced today that it has concluded a Licensing Agreement with Duke University for the acquisition of certain intellectual property associated with the delivery of therapeutic agents based on ELP technology. Under the terms of the agreement PhaseBio will have worldwide rights to use the technology to develop its own portfolio of products as well as enter into third party arrangements for co-development and licensing.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES